Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by gregoooon Jan 18, 2012 1:02pm
603 Views
Post# 19417571

RE: sky is the limit......$$$$

RE: sky is the limit......$$$$

So they should have the Long Term Production Test permit by mid Feb - then based on 2000 bopd - net 1800 bopd to QEI and BWN the well should pay for itself in less than 100 days- 1800 bopd x $90/bbl=$162,000 /day - $16,000,000 to drill and complete. Then QEI drops to 35% x 2000bopd = 700 bopd plus the current 300 bopd equates to 1000 bopd net. as above take off $10/bbl op.costs and QEI has fantastic cash flow= $90,000 /day.approx $2,700,000 / month = $32,400,000 / year. Current market cap $48,000,000.  Cash flow per share .08 - just what we are trading at. I understand  that oil and gas stocks normally trade at 8-10 times cashflow ( correct me if I am wrong here) which would be a lot higher than the current level- imo. Should have lots of cash to drill a few more wells this year - 2 in Block 21 and then another 1 or 2 in Block 27?

Should have the environmental permit for block 21 in March - applied for in August and 8-9 months as per Block 27's time for approval and drill in May/June before the September dead line.

Maybe we will get an operational update from management soon. 

Bullboard Posts